GFG Capital’s Medtronic MDT Stock Holding History

GFG Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-415	Closed	-$36.2K	–	231
2025 Q2	$36.2K	Buy	+415	New	+$35.2K	0.01%	122

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GFG Capital's MDT Position: Q3 2025 in Review

GFG Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 415 shares — an estimated $36.2K sold.

GFG Capital first reported a position in MDT in Q2 2025 and held it in 1 quarter. The position peaked at $36.2K in Q2 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

GFG Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
GFG Capital sold 415 Medtronic shares in Q3 2025, an estimated $36.2K.
GFG Capital first reported a position in Medtronic in Q2 2025 and held it in 1 quarter.
GFG Capital's Medtronic position peaked at $36.2K in Q2 2025.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.